BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kashte S, Gulbake A, El-Amin Iii SF, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell 2021;34:711-33. [PMID: 33677814 DOI: 10.1007/s13577-021-00512-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 73] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Behera P, Singh AK, Subba SH, Mc A, Sahu DP, Chandanshive PD, Pradhan SK, Parida SP, Mishra A, Patro BK, Batmanabane G. Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India. Hum Vaccin Immunother 2022;18:2034456. [PMID: 35321625 DOI: 10.1080/21645515.2022.2034456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Pang Y, Li X, Zhong W, Gong D, Chang Q, Zhong Z, Guo P, Sun G. Quality assessment of liquorice combined with quantum fingerprint profiles and electrochemical activity. Microchemical Journal 2022;181:107804. [DOI: 10.1016/j.microc.2022.107804] [Reference Citation Analysis]
3 Khan MM, Goh YW, Ahmad N, Siddique MM. Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2. Bioprocess Biosyst Eng 2022. [PMID: 36125525 DOI: 10.1007/s00449-022-02788-8] [Reference Citation Analysis]
4 Rahmandad H, Sterman J. Quantifying the COVID ‐19 endgame: Is a new normal within reach? System Dynamics Review. [DOI: 10.1002/sdr.1715] [Reference Citation Analysis]
5 Fajar JK, Sallam M, Soegiarto G, Sugiri YJ, Anshory M, Wulandari L, Kosasih SAP, Ilmawan M, Kusnaeni K, Fikri M, Putri F, Hamdi B, Pranatasari ID, Aina L, Maghfiroh L, Ikhriandanti FS, Endiaverni WO, Nugraha KW, Wiranudirja O, Edinov S, Hamdani U, Rosyidah L, Lubaba H, Ariwibowo R, Andistyani R, Fitriani R, Hasanah M, Nafis FAD, Tamara F, Latamu FO, Kusuma HI, Rabaan AA, Alhumaid S, Mutair AA, Garout M, Halwani MA, Alfaresi M, Al Azmi R, Alasiri NA, Alshukairi AN, Dhama K, Harapan H. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines (Basel) 2022;10:1356. [PMID: 36016242 DOI: 10.3390/vaccines10081356] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chavda VP, Chen Y, Dave J, Chen ZS, Chauhan SC, Yallapu MM, Uversky VN, Bezbaruah R, Patel S, Apostolopoulos V. COVID-19 and vaccination: myths vs science. Expert Rev Vaccines 2022. [PMID: 35980281 DOI: 10.1080/14760584.2022.2114900] [Reference Citation Analysis]
7 Xia Y, Yao R, Zhao P, Tao Z, Zheng L, Zhou H, Yao Y, Song X. Publication trends of research on COVID-19 and host immune response: A bibliometric analysis. Front Public Health 2022;10:939053. [DOI: 10.3389/fpubh.2022.939053] [Reference Citation Analysis]
8 Yesuf EA, Riad A, Sofi-mahmudi A, Sudhakar M, Mekonnen A, Endalkachew S, Mama F, Muhidin S, Ayele B, Yahya M, Usman A, Abafita J, Klugar M. Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study. Front Public Health 2022;10:937794. [DOI: 10.3389/fpubh.2022.937794] [Reference Citation Analysis]
9 Rodríguez A, Cuevas E, Zaldivar D, Morales-castañeda B, Sarkar R, Houssein EH. An agent-based transmission model of COVID-19 for re-opening policy design. Computers in Biology and Medicine 2022. [DOI: 10.1016/j.compbiomed.2022.105847] [Reference Citation Analysis]
10 Grenfell RFQ, Oyeyemi OT. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study. Pathog Glob Health 2022;:1-15. [PMID: 35770309 DOI: 10.1080/20477724.2022.2091862] [Reference Citation Analysis]
11 Mugo PM, Mumbi A, Munene D, Nzinga J, Molyneux S, Barasa E; PSK COVID-19 Response Taskforce. Experiences of and response to the COVID-19 pandemic at private retail pharmacies in Kenya: a mixed-methods study. BMJ Open 2022;12:e058688. [PMID: 35768121 DOI: 10.1136/bmjopen-2021-058688] [Reference Citation Analysis]
12 Sun C, Xie C, Bu GL, Zhong LY, Zeng MS. Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Signal Transduct Target Ther 2022;7:202. [PMID: 35764603 DOI: 10.1038/s41392-022-01039-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
13 Shekhar SK. Social Marketing Plan to Decrease the COVID-19 Vaccine Hesitancy among Senior Citizens in Rural India. Sustainability 2022;14:7561. [DOI: 10.3390/su14137561] [Reference Citation Analysis]
14 Limbu YB, Gautam RK, Pham L. The Health Belief Model Applied to COVID-19 Vaccine Hesitancy: A Systematic Review. Vaccines (Basel) 2022;10:973. [PMID: 35746581 DOI: 10.3390/vaccines10060973] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Sun C, Yuan RY, Xie C, Sun JF, Fang XY, Hu YS, Yu XH, Liu Z, Zeng MS, Kang YF. Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines. J Virol 2022;:e0038322. [PMID: 35699445 DOI: 10.1128/jvi.00383-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cortés-Sarabia K, Gutiérrez-Torres M, Mendoza-Renteria EM, Leyva-Vázquez MA, Vences-Velázquez A, Hernández-Sotelo D, Beltrán-Anaya FO, Del Moral-Hernández O, Illades-Aguiar B. Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review. Vaccines (Basel) 2022;10:909. [PMID: 35746517 DOI: 10.3390/vaccines10060909] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
17 Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev 2022;185:114294. [PMID: 35436569 DOI: 10.1016/j.addr.2022.114294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wester CT, Bovil T, Scheel-hincke LL, Ahrenfeldt LJ, Möller S, Andersen-ranberg K. Longitudinal changes in mental health following the COVID-19 lockdown: Results from the Survey of Health, Ageing and Retirement in Europe. Annals of Epidemiology 2022. [DOI: 10.1016/j.annepidem.2022.05.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Seddig D, Maskileyson D, Davidov E, Ajzen I, Schmidt P. Correlates of COVID-19 vaccination intentions: Attitudes, institutional trust, fear, conspiracy beliefs, and vaccine skepticism. Soc Sci Med 2022;302:114981. [PMID: 35512613 DOI: 10.1016/j.socscimed.2022.114981] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
20 Al-amer R, Malak MZ, Burqan HMR, Stănculescu E, Nalubega S, Alkhamees AA, Hendawy AO, Ali AM. Emotional Reaction to the First Dose of COVID-19 Vaccine: Postvaccination Decline in Anxiety and Stress among Anxious Individuals and Increase among Individuals with Normal Prevaccination Anxiety Levels. JPM 2022;12:912. [DOI: 10.3390/jpm12060912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hekmati A, Luhar M, Krishnamachari B, Matarić M. Simulating COVID-19 classroom transmission on a university campus. Proc Natl Acad Sci U S A 2022;119:e2116165119. [PMID: 35609196 DOI: 10.1073/pnas.2116165119] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hassan J, Haigh C, Ahmed T, Uddin MJ, Das DB. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics 2022;14:1066. [DOI: 10.3390/pharmaceutics14051066] [Reference Citation Analysis]
23 Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19). Cell Mol Biol Lett 2022;27:38. [PMID: 35562685 DOI: 10.1186/s11658-022-00339-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Beg BM, Hussain T, Ahmad M, Areej S, Majeed A, Rasheed MA, Ahmad MM, Shoaib QU, Aroosa S. Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan. PLoS One 2022;17:e0266028. [PMID: 35324978 DOI: 10.1371/journal.pone.0266028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Barcellos-paula L, Gil-lafuente AM, Castro-rezende A. Socio-Economic and Health Management of Pandemics Based on Forgotten Effects Theory. Cybernetics and Systems. [DOI: 10.1080/01969722.2022.2058693] [Reference Citation Analysis]
26 Hagger MS, Hamilton K. Social cognition theories and behavior change in COVID-19: A conceptual review. Behaviour Research and Therapy 2022. [DOI: 10.1016/j.brat.2022.104095] [Reference Citation Analysis]
27 Yang Z, Zhang S, Tang YP, Zhang S, Xu DQ, Yue SJ, Liu QL. Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants. Aging Dis 2022;13:402-22. [PMID: 35371608 DOI: 10.14336/AD.2021.1210] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Aileni M, Rohela GK, Jogam P, Soujanya S, Zhang B. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms. Cells 2022;11:1182. [DOI: 10.3390/cells11071182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 Belete TM. The Immune Response, Safety, and Efficacy of Emergency Use Authorization-Granted COVID-19 Vaccines: A Review. TOMICROJ 2022;16:e187428582201240. [DOI: 10.2174/18742858-v16-e2201240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Rabail R, Ahmed W, Ilyas M, Rajoka MSR, Hassoun A, Khalid AR, Khan MR, Aadil RM. The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization. Vaccines (Basel) 2022;10:488. [PMID: 35455237 DOI: 10.3390/vaccines10040488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Hamilton K, Hagger MS. The Vaccination Concerns in COVID-19 Scale (VaCCS): Development and validation. PLoS One 2022;17:e0264784. [PMID: 35286331 DOI: 10.1371/journal.pone.0264784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
32 Dighriri IM, Alhusayni KM, Mobarki AY, Aljerary IS, Alqurashi KA, Aljuaid FA, Alamri KA, Mutwalli AA, Maashi NA, Aljohani AM, Alqarni AM, Alfaqih AE, Moazam SM, Almutairi MN, Almutairi AN. Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review. Cureus 2022;14:e23526. [PMID: 35494952 DOI: 10.7759/cureus.23526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Choi JA, Kim JO. Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies. J Microbiol 2022;60:238-46. [PMID: 35089585 DOI: 10.1007/s12275-022-1547-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Rusgis MM, Bays JE, Abt RM, Sperry ML. Impact of COVID-19 health information sources on student vaccine hesitancy. Currents in Pharmacy Teaching and Learning 2022. [DOI: 10.1016/j.cptl.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Bertacchini de Oliveira L, Mendes de Souza L, Maria de Lima F, Silva Fhon JR, Alves de Araújo Püschel V, da Costa Carbogim F. Factors Associated With the Illness of Nursing Professionals Caused by COVID-19 in Three University Hospitals in Brazil. Safety and Health at Work 2022. [DOI: 10.1016/j.shaw.2022.03.001] [Reference Citation Analysis]
36 Marić J, Gama-araujo I. Implications of the COVID-19 pandemic in education and vaccine hesitancy among students: a cross-sectional analysis from France. International Journal of Logistics Research and Applications. [DOI: 10.1080/13675567.2022.2042225] [Reference Citation Analysis]
37 Hamley IW. Peptides for Vaccine Development. ACS Appl Bio Mater 2022. [PMID: 35195008 DOI: 10.1021/acsabm.1c01238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Hagger MS, Hamilton K. Predicting COVID-19 booster vaccine intentions. Appl Psychol Health Well Being 2022. [PMID: 35193171 DOI: 10.1111/aphw.12349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Res 2022. [PMID: 35192185 DOI: 10.1007/s12026-022-09265-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Budziar W, Gembara K, Harhala M, Szymczak A, Jędruchniewicz N, Baniecki K, Pikies A, Nahorecki A, Hoffmann A, Kardaś A, Szewczyk-Dąbrowska A, Klimek T, Kaźmierczak Z, Witkiewicz W, Barczyk K, Dąbrowska K. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. PLoS One 2022;17:e0253638. [PMID: 35113873 DOI: 10.1371/journal.pone.0253638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Jin Y, Hou C, Li Y, Zheng K, Wang C. mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2. Front Immunol 2022;12:821538. [DOI: 10.3389/fimmu.2021.821538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
42 Dey SK, Rahman MM, Siddiqi UR, Howlader A, Tushar MA, Qazi A. Global landscape of COVID-19 vaccination progress: insight from an exploratory data analysis. Hum Vaccin Immunother 2022;:1-10. [PMID: 35050838 DOI: 10.1080/21645515.2021.2025009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Mukherjee PK, Efferth T, Das B, Kar A, Ghosh S, Singha S, Debnath P, Sharma N, Bhardwaj PK, Haldar PK. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications. Phytomedicine 2022;98:153930. [PMID: 35114450 DOI: 10.1016/j.phymed.2022.153930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
44 Shankaranarayanan A, Wei H. . MBE 2022;19:11324-44. [DOI: 10.3934/mbe.2022527] [Reference Citation Analysis]
45 Santana-mederos D, Perez-nicado R, Climent Y, Rodriguez L, Ramirez BS, Perez-rodriguez S, Rodriguez M, Labrada C, Hernandez T, Diaz M, Orosa I, Ramirez U, Oliva R, Garrido R, Cardoso F, Landys M, Martinez R, Gonzalez H, Hernandez T, Ochoa-azze R, Perez JL, Enriquez J, Gonzalez N, Infante Y, Espinosa LA, Ramos Y, González LJ, Valenzuela C, Casadesus AV, Fernandez B, Rojas G, Pérez-massón B, Tundidor Y, Bermudez E, Plasencia CA, Boggiano T, Ojito E, Chiodo F, Fernandez S, Paquet F, Fang C, Chen G, Rivera DG, Valdes-balbin Y, Garcia-rivera D, Verez Bencomo V. A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles. RSC Chem Biol . [DOI: 10.1039/d1cb00200g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Lim WW, Cowling BJ. Mechanistic Correlates of Protection for SARS-CoV-2 Vaccines. Epidemiology 2022;33:e1. [PMID: 34799478 DOI: 10.1097/EDE.0000000000001419] [Reference Citation Analysis]
47 Gaweł A, Mańdziuk M, Żmudziński M, Gosek M, Krawczyk-Suszek M, Pisarski M, Adamski A, Cyganik W. Effects of Pope Francis' Religious Authority and Media Coverage on Twitter User's Attitudes toward COVID-19 Vaccination. Vaccines (Basel) 2021;9:1487. [PMID: 34960233 DOI: 10.3390/vaccines9121487] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Paula HSC, Santiago SB, Araújo LA, Pedroso CF, Marinho TA, Gonçalves IAJ, Santos TAP, Pinheiro RS, Oliveira GA, Batista KA. An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic. Braz J Med Biol Res 2021;55:e11631. [PMID: 34909910 DOI: 10.1590/1414-431X2021e11631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chudasama RV, Khunti K, Ekezie WC, Pareek M, Zaccardi F, Gillies CL, Seidu S, Davies MJ, Chudasama YV. COVID-19 vaccine uptake and hesitancy opinions from frontline health care and social care workers: Survey data from 37 countries. Diabetes Metab Syndr 2021;16:102361. [PMID: 34920206 DOI: 10.1016/j.dsx.2021.102361] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
50 He Z, Xiang H, Manyande A, Xu W, Fan L, Xiang B. Epidemiological Characteristics of Sporadic Nosocomial COVID-19 Infections From June 2020 to June 2021 in China: An Overview of Vaccine Breakthrough Infection Events. Front Med (Lausanne) 2021;8:736060. [PMID: 34778299 DOI: 10.3389/fmed.2021.736060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Trimpert J, Herwig S, Stein J, Vladimirova D, Adler JM, Abdelgawad A, Firsching TC, Thoma T, Sehouli J, Osterrieder K, Gruber AD, Sawitzki B, Sander LE, Cichon G. Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters. Viruses 2021;13:2290. [PMID: 34835096 DOI: 10.3390/v13112290] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
52 Bateman LB, Hall AG, Anderson WA, Cherrington AL, Helova A, Judd S, Kimberly R, Oates GR, Osborne T, Ott C, Ryan M, Strong C, Fouad MN. Exploring COVID-19 Vaccine Hesitancy Among Stakeholders in African American and Latinx Communities in the Deep South Through the Lens of the Health Belief Model. Am J Health Promot 2021;:8901171211045038. [PMID: 34719985 DOI: 10.1177/08901171211045038] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
53 Unal Enginar A. Arthritis following COVID-19 vaccination: report of two cases. Int Immunopharmacol 2021;101:108256. [PMID: 34673298 DOI: 10.1016/j.intimp.2021.108256] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
54 Ghaffari S, Kazerooni H, Salehi-Najafabadi A. An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19. Int Immunopharmacol 2021;101:108226. [PMID: 34634685 DOI: 10.1016/j.intimp.2021.108226] [Reference Citation Analysis]
55 Rana R, Tripathi A, Kumar N, Ganguly NK. A Comprehensive Overview on COVID-19: Future Perspectives. Front Cell Infect Microbiol 2021;11:744903. [PMID: 34595136 DOI: 10.3389/fcimb.2021.744903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
56 Asada K, Komatsu M, Shimoyama R, Takasawa K, Shinkai N, Sakai A, Bolatkan A, Yamada M, Takahashi S, Machino H, Kobayashi K, Kaneko S, Hamamoto R. Application of Artificial Intelligence in COVID-19 Diagnosis and Therapeutics. J Pers Med 2021;11:886. [PMID: 34575663 DOI: 10.3390/jpm11090886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
57 Mohan S, Anjum MR, Kodidasu A, Prathyusha TVNS, Mrunalini NV, Kishori B. SARS-CoV-2 infection: a global outbreak and its implication on public health. Bull Natl Res Cent 2021;45:139. [PMID: 34366657 DOI: 10.1186/s42269-021-00599-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Jin T, Xu Y, Dai C, Zhou X, Xu Q, Wu Z. Cold atmospheric plasma: A non-negligible strategy for viral RNA inactivation to prevent SARS-CoV-2 environmental transmission. AIP Adv 2021;11:085019. [PMID: 34413992 DOI: 10.1063/5.0060530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
59 Chavda VP, Vora LK, Pandya AK, Patravale VB. Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management. Drug Discov Today 2021:S1359-6446(21)00331-7. [PMID: 34332100 DOI: 10.1016/j.drudis.2021.07.021] [Cited by in F6Publishing: 49] [Reference Citation Analysis]
60 Datta R. Real life vaccine effectiveness against COVID-19: Proof of the pudding! Med J Armed Forces India 2021;77:S235-6. [PMID: 34334885 DOI: 10.1016/j.mjafi.2021.07.008] [Reference Citation Analysis]
61 Valdes-Balbin Y, Santana-Mederos D, Quintero L, Fernández S, Rodriguez L, Sanchez Ramirez B, Perez-Nicado R, Acosta C, Méndez Y, Ricardo MG, Hernandez T, Bergado G, Pi F, Valdes A, Carmenate T, Ramirez U, Oliva R, Soubal JP, Garrido R, Cardoso F, Landys M, Gonzalez H, Farinas M, Enriquez J, Noa E, Suarez A, Fang C, Espinosa LA, Ramos Y, González LJ, Climent Y, Rojas G, Relova-Hernández E, Cabrera Infante Y, Losada SL, Boggiano T, Ojito E, León K, Chiodo F, Paquet F, Chen GW, Rivera DG, Garcia-Rivera D, Verez Bencomo V. SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies. ACS Chem Biol 2021;16:1223-33. [PMID: 34219448 DOI: 10.1021/acschembio.1c00272] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
62 Guida M, Terracciano D, Cennamo M, Aiello F, La Civita E, Esposito G, Gargiulo V, Maruotti GM, Portella G, Sarno L. COVID-19 Vaccine mRNABNT162b2 Elicits Human Antibody Response in Milk of Breastfeeding Women. Vaccines (Basel) 2021;9:785. [PMID: 34358201 DOI: 10.3390/vaccines9070785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
63 Rzymski P, Pazgan-Simon M, Simon K, Łapiński T, Zarębska-Michaluk D, Szczepańska B, Chojnicki M, Mozer-Lisewska I, Flisiak R. Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine. Vaccines (Basel) 2021;9:781. [PMID: 34358197 DOI: 10.3390/vaccines9070781] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
64 Hamley IW. Lipopeptides for Vaccine Development. Bioconjug Chem 2021. [PMID: 34228433 DOI: 10.1021/acs.bioconjchem.1c00258] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
65 Rizwan T, Kothidar A, Meghwani H, Sharma V, Shobhawat R, Saini R, Vaishnav HK, Singh V, Pratap M, Sihag H, Kumar S, Dey JK, Dey SK. Comparative analysis of SARS-CoV-2 envelope viroporin mutations from COVID-19 deceased and surviving patients revealed implications on its ion-channel activities and correlation with patient mortality. J Biomol Struct Dyn 2021;:1-16. [PMID: 34229570 DOI: 10.1080/07391102.2021.1944319] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
66 Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021;12:658519. [PMID: 34276652 DOI: 10.3389/fimmu.2021.658519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
67 Monzavi SM, Naderi M, Ahmadbeigi N, Kajbafzadeh AM, Muhammadnejad S. An outlook on antigen-specific adoptive immunotherapy for viral infections with a focus on COVID-19. Cell Immunol 2021;367:104398. [PMID: 34217004 DOI: 10.1016/j.cellimm.2021.104398] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
68 Damodharan K, Arumugam GS, Ganesan S, Doble M, Thennarasu S. A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2. RSC Adv 2021;11:20006-35. [PMID: 35479882 DOI: 10.1039/d0ra09668g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Zafarnejad R, Griffin PM. Assessing school-based policy actions for COVID-19: An agent-based analysis of incremental infection risk. Comput Biol Med 2021;134:104518. [PMID: 34102403 DOI: 10.1016/j.compbiomed.2021.104518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
70 Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, Mohamud R. Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects. Vaccines (Basel) 2021;9:556. [PMID: 34073382 DOI: 10.3390/vaccines9060556] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 60.0] [Reference Citation Analysis]
71 Jain J, Saurabh S, Kumar P, Verma MK, Goel AD, Gupta MK, Bhardwaj P, Raghav PR. COVID-19 vaccine hesitancy among medical students in India. Epidemiol Infect 2021;149:e132. [PMID: 34011421 DOI: 10.1017/S0950268821001205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
72 Ma C, Xu S, Yao Y, Yu P, Xu Y, Wu R, Chen H, Dong X. Mild Breakthrough Infection in a Healthcare Professional Working in the Isolation Area of a Hospital Designated for Treating COVID-19 Patients - Shaanxi Province, China, March, 2021. China CDC Wkly 2021;3:397-400. [PMID: 34594892 DOI: 10.46234/ccdcw2021.094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Faizo AA, Alandijany TA, Abbas AT, Sohrab SS, El-Kafrawy SA, Tolah AM, Hassan AM, Azhar EI. A Reliable Indirect ELISA Protocol for Detection of Human Antibodies Directed to SARS-CoV-2 NP Protein. Diagnostics (Basel) 2021;11:825. [PMID: 34063315 DOI: 10.3390/diagnostics11050825] [Cited by in F6Publishing: 2] [Reference Citation Analysis]